Group One Trading’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150K | Sell |
88,900
-308,500
| -78% | -$635K | ﹤0.01% | 4357 |
|
|
2025
Q4 | $787K | Sell |
397,400
-83,400
| -17% | -$267K | ﹤0.01% | 3108 |
|
|
2025
Q3 | $1.4M | Buy |
480,800
+114,400
| +31% | +$263K | ﹤0.01% | 2676 |
|
|
2025
Q2 | $663K | Sell |
366,400
-137,000
| -27% | -$244K | ﹤0.01% | 3143 |
|
|
2025
Q1 | $755K | Sell |
503,400
-160,400
| -24% | -$405K | ﹤0.01% | 2709 |
|
|
2024
Q4 | $1.57M | Buy |
663,800
+61,800
| +10% | +$1.09M | ﹤0.01% | 2130 |
|
|
2024
Q3 | $17.7M | Sell |
602,000
-32,200
| -5% | -$742K | 0.05% | 325 |
|
|
2024
Q2 | $7.83M | Buy |
634,200
+152,400
| +32% | +$3.21M | 0.03% | 565 |
|
|
2024
Q1 | $9.78M | Sell |
481,800
-531,400
| -52% | -$12.2M | 0.04% | 460 |
|
|
2023
Q4 | $22.8M | Buy |
1,013,200
+483,500
| +91% | +$10.2M | 0.06% | 300 |
|
|
2023
Q3 | $8.81M | Buy |
529,700
+228,800
| +76% | +$4.53M | 0.03% | 595 |
|
|
2023
Q2 | $7.38M | Sell |
300,900
-161,800
| -35% | -$3.9M | 0.02% | 699 |
|
|
2023
Q1 | $11.2M | Sell |
462,700
-588,900
| -56% | -$16.3M | 0.04% | 417 |
|
|
2022
Q4 | $31.1M | Sell |
1,051,600
-194,700
| -16% | -$7M | 0.07% | 266 |
|
|
2022
Q3 | $52.1M | Buy |
1,246,300
+431,800
| +53% | +$11.7M | 0.1% | 129 |
|
|
2022
Q2 | $22.9M | Buy |
814,500
+352,800
| +76% | +$8.91M | 0.04% | 419 |
|
|
2022
Q1 | $17.1M | Sell |
461,700
-246,000
| -35% | -$10.4M | 0.02% | 689 |
|
|
2021
Q4 | $30.9M | Buy |
707,700
+195,800
| +38% | +$10.3M | 0.02% | 479 |
|
|
2021
Q3 | $31.8M | Buy |
511,900
+304,900
| +147% | +$25.4M | 0.03% | 412 |
|
|
2021
Q2 | $17.7M | Sell |
207,000
-274,500
| -57% | -$14.7M | 0.02% | 707 |
|
|
2021
Q1 | $21.6M | Buy |
481,500
+365,300
| +314% | +$14.4M | 0.03% | 507 |
|
|
2020
Q4 | $792K | Buy |
116,200
+27,000
| +30% | +$241K | ﹤0.01% | 2853 |
|
|
2020
Q3 | $1.03M | Sell |
89,200
-101,500
| -53% | -$458K | ﹤0.01% | 2165 |
|
|
2020
Q2 | $587K | Buy |
190,700
+187,800
| +6,476% | +$852K | ﹤0.01% | 2498 |
|
|
2020
Q1 | $12K | Buy |
+2,900
| New | +$19.2K | ﹤0.01% | 4493 |
|
|
2014
Q4 | – | Sell |
-2,671
| Closed | -$73K | – | 5224 |
|
|
2014
Q3 | $73K | Sell |
2,671
-2,015
| -43% | -$61.2K | ﹤0.01% | 3259 |
|
|
2014
Q2 | $189K | Sell |
4,686
-2,485
| -35% | -$92K | ﹤0.01% | 2458 |
|
|
2014
Q1 | $276K | Buy |
7,171
+4,271
| +147% | +$151K | ﹤0.01% | 2166 |
|
|
2013
Q4 | $99K | Buy |
2,900
+1,214
| +72% | +$32.2K | ﹤0.01% | 3041 |
|
|
2013
Q3 | $32K | Sell |
1,686
-2,228
| -57% | -$38.9K | ﹤0.01% | 3876 |
|
|
2013
Q2 | $61K | Buy |
+3,914
| New | +$82.7K | ﹤0.01% | 3251 |
|
Other funds holding FLNA
VCM
GC
Group One Trading's FLNA Position: Q1 2026 in Review
Group One Trading increased its Filana Therapeutics (FLNA) stake by 12% in Q1 2026, buying an estimated $68.3K and bringing the position to 302,624 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #3324.
Group One Trading first reported a position in FLNA in Q3 2013 and has held it in 34 quarters since. The position peaked at $46.5M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Group One Trading held 302,624 shares of Filana Therapeutics worth $511K as of Q1 2026.
- Group One Trading bought 33,154 Filana Therapeutics shares in Q1 2026, an estimated $68.3K.
- Filana Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3324 holding.
- Group One Trading first reported a position in Filana Therapeutics in Q3 2013 and has held it in 34 quarters since.
- Group One Trading's Filana Therapeutics position peaked at $46.5M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.